long-acting antibodies

Sanofi and Regeneron Expand 20-Year Alliance With $1 Billion Deal for Long-Acting Immunology Antibodies The Sanofi Regeneron deal has expanded the pharmaceutical companies’ more than 20-year collaboration, with Sanofi agreeing …